Cardiac adverse event profiles of EGFR tyrosine kinase inhibitors: a disproportionality analysis using eudravigilance
9 May 2026 (08:00 - 12:45)
Organised by: 

About the speaker

University of Medicine and Pharmacy Carol Davila, Bucharest (Romania)
5 More presentations in this session
Doctor R. Brandao (Amadora, PT)
Access the full session
The Event
Heart Failure 2026
9 May - 12 May 2026

